Skip to main content
Log in

Clinical Application of Frailty in the Evaluation of Solid Organ Transplant Patients

  • Published:
Current Transplantation Reports Aims and scope Submit manuscript

Abstract

Purpose of review

Frailty is increasingly recognized as an important predictor of mortality and morbidity in patients across various medical subspecialties. The purpose of this review is to assess how frailty and markers of functional status are viewed within the field of transplant and incorporated into patient evaluations.

Recent Findings

Frailty has been shown to influence patient and graft outcomes and many centers incorporate some form of frailty assessment during transplant candidacy evaluation. However, the optimal methods for assessing frailty have not been defined for solid organ transplant populations, and there is no standard approach among different centers. Subjective measures of functional status are recorded in national registries at the time of waitlisting but are largely not used when determining waitlist priority.

Summary

This review focuses on currently used tools for assessing frailty in transplant patients and consensus recommendations for future application of frailty in this population.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Organ distribution [Internet]. UNOS. [cited 2024 Mar 4]. Available from: https://unos.org/policy/organ-distribution/

  2. • Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001;56:M146-156. (Seminal paper describing the now widely used Fried Frailty Phenotype scoring system to assess frailty in geriatric patients)

    Article  CAS  PubMed  Google Scholar 

  3. Morley JE, Vellas B, van Kan GA, Anker SD, Bauer JM, Bernabei R, et al. Frailty consensus: a call to action. J Am Med Dir Assoc. 2013;14:392–7.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Huisingh-Scheetz M, Walston J. How should older adults with cancer be evaluated for frailty? J Geriatr Oncol. 2017;8:8–15.

    Article  PubMed  Google Scholar 

  5. • Buta BJ, Walston JD, Godino JG, Park M, Kalyani RR, Xue Q-L, et al. Frailty assessment instruments: Systematic characterization of the uses and contexts of highly-cited instruments. Ageing Res Rev. 2016;26:53–61. (Comprehensive review of multiple frailty metrics and their current use)

    Article  PubMed  Google Scholar 

  6. Huisingh-Scheetz M, Martinchek M, Becker Y, Ferguson MK, Thompson K. Translating Frailty Research Into Clinical Practice: Insights From the Successful Aging and Frailty Evaluation Clinic. J Am Med Dir Assoc. 2019;20:672–8.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Bandeen-Roche K, Gross AL, Varadhan R, Buta B, Carlson MC, Huisingh-Scheetz M, et al. Principles and Issues for Physical Frailty Measurement and Its Clinical Application. J Gerontol A Biol Sci Med Sci. 2020;75:1107–12.

    Article  PubMed  Google Scholar 

  8. Theou O, Brothers TD, Peña FG, Mitnitski A, Rockwood K. Identifying common characteristics of frailty across seven scales. J Am Geriatr Soc. 2014;62:901–6.

    Article  PubMed  Google Scholar 

  9. Bergman H, Ferrucci L, Guralnik J, Hogan DB, Hummel S, Karunananthan S, et al. Frailty: an emerging research and clinical paradigm–issues and controversies. J Gerontol A Biol Sci Med Sci. 2007;62:731–7.

    Article  PubMed  Google Scholar 

  10. Bendayan M, Bibas L, Levi M, Mullie L, Forman DE, Afilalo J. Therapeutic interventions for frail elderly patients: part II. Ongoing and unpublished randomized trials. Prog Cardiovasc Dis. 2014;57:144–51.

  11. Bibas L, Levi M, Bendayan M, Mullie L, Forman DE, Afilalo J. Therapeutic interventions for frail elderly patients: part I Published randomized trials. Prog Cardiovasc Dis. 2014;57:134–43.

    Article  PubMed  Google Scholar 

  12. Freiberger E, Kemmler W, Siegrist M, Sieber C. Frailty and exercise interventions : Evidence and barriers for exercise programs. Z Gerontol Geriatr. 2016;49:606–11.

    Article  CAS  PubMed  Google Scholar 

  13. Fried LP. Interventions for Human Frailty: Physical Activity as a Model. Cold Spring Harb Perspect Med. 2016;6:a025916.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Kelaiditi E, van Kan GA, Cesari M. Frailty: role of nutrition and exercise. Curr Opin Clin Nutr Metab Care. 2014;17:32–9.

    PubMed  Google Scholar 

  15. Lee P-H, Lee Y-S, Chan D-C. Interventions targeting geriatric frailty: a systemic review. Journal of Clinical Gerontology and Geriatrics. 2012;47–52.

  16. Macdonald SH-F, Travers J, Shé ÉN, Bailey J, Romero-Ortuno R, Keyes M, et al. Primary care interventions to address physical frailty among community-dwelling adults aged 60 years or older: A meta-analysis. PLoS One. 2020;15:e0228821.

  17. Pazan F, Petrovic M, Cherubini A, Onder G, Cruz-Jentoft AJ, Denkinger M, et al. Current evidence on the impact of medication optimization or pharmacological interventions on frailty or aspects of frailty: a systematic review of randomized controlled trials. Eur J Clin Pharmacol. 2021;77:1–12.

    Article  CAS  PubMed  Google Scholar 

  18. Puts MTE, Toubasi S, Andrew MK, Ashe MC, Ploeg J, Atkinson E, et al. Interventions to prevent or reduce the level of frailty in community-dwelling older adults: a scoping review of the literature and international policies. Age Ageing. 2017;46:383–92.

    PubMed  PubMed Central  Google Scholar 

  19. Rolland Y, Dupuy C, Abellan van Kan G, Gillette S, Vellas B. Treatment strategies for sarcopenia and frailty. Med Clin North Am. 2011;95:427–38, ix.

  20. Tarazona-Santabalbina FJ, Gómez-Cabrera MC, Pérez-Ros P, Martínez-Arnau FM, Cabo H, Tsaparas K, et al. A Multicomponent Exercise Intervention that Reverses Frailty and Improves Cognition, Emotion, and Social Networking in the Community-Dwelling Frail Elderly: A Randomized Clinical Trial. J Am Med Dir Assoc. 2016;17:426–33.

    Article  PubMed  Google Scholar 

  21. Theou O, Stathokostas L, Roland KP, Jakobi JM, Patterson C, Vandervoort AA, et al. The effectiveness of exercise interventions for the management of frailty: a systematic review. J Aging Res. 2011;2011:569194.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Turner G, Clegg A, British Geriatrics Society, Age UK, Royal College of General Practioners. Best practice guidelines for the management of frailty: a British Geriatrics Society, Age UK and Royal College of General Practitioners report. Age Ageing. 2014;43:744–7.

  23. Won CW, Kim S. Use of Frailty in Deciding Clinical Treatment Goals for Chronic Disease in Elderly Patients in the Community. J Am Med Dir Assoc. 2016;17:967–9.

    Article  PubMed  Google Scholar 

  24. • Bottiger BA, Nicoara A, Snyder LD, Wischmeyer PE, Schroder JN, Patel CB, et al. Frailty in the End-Stage Lung Disease or Heart Failure Patient: Implications for the Perioperative Transplant Clinician. J Cardiothorac Vasc Anesth. 2019;33:1382–92. (Discusses how to address and consider frailty in advanced lung and heart disease patients undergoing transplant evaluation.)

    Article  PubMed  Google Scholar 

  25. Lee YK, Shukman M, Biniwale R, Ardehali A, Kamath M, Nsair A, et al. Benefits of both physical assessment and electronic health record review to assess frailty prior to heart transplant. Clin Transplant. 2022;36:e14559.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Boureau A-S, Annweiler C, Belmin J, Bouleti C, Chacornac M, Chuzeville M, et al. Practical management of frailty in older patients with heart failure: Statement from a panel of multidisciplinary experts on behalf the Heart Failure Working Group of the French Society of Cardiology and on behalf French Society of Geriatrics and Gerontology. ESC Heart Fail. 2022;9:4053–63.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Denfeld QE, Jha SR, Fung E, Jaarsma T, Maurer MS, Reeves GR, et al. Assessing and managing frailty in advanced heart failure: An International Society for Heart and Lung Transplantation consensus statement. J Heart Lung Transplant. 2023;S1053–2498(23):02028–34.

    Google Scholar 

  28. Macdonald P. Frailty of the Heart Recipient. Transplantation. 2021;105:2352–61.

    Article  PubMed  Google Scholar 

  29. Ayesta A, Valero Masa MJ, Vidán MT, Luna-López R, Segovia-Cubero J, García-Cosío MD, et al. Prevalence and characterization of frailty, depression, and cognitive impairment in patients listed for heart transplantation: Results of the FELICITAR prospective registry. Clin Transplant. 2021;35:e14391.

    Article  PubMed  Google Scholar 

  30. Kobashigawa J, Shah P, Joseph S, Olymbios M, Bhat G, Dhital K, et al. Frailty in heart transplantation: Report from the heart workgroup of a consensus conference on frailty. Am J Transplant. 2021;21:636–44.

    Article  PubMed  Google Scholar 

  31. Jha SR, Hannu MK, Gore K, Chang S, Newton P, Wilhelm K, et al. Cognitive impairment improves the predictive validity of physical frailty for mortality in patients with advanced heart failure referred for heart transplantation. J Heart Lung Transplant. 2016;35:1092–100.

    Article  PubMed  Google Scholar 

  32. Seese L, Hirji S, Sultan I, Gleason T, Kilic A. Frailty Screening Tool for Patients Undergoing Orthotopic Heart Transplant. Ann Thorac Surg. 2021;111:586–93.

    Article  PubMed  Google Scholar 

  33. Mehra MR, Canter CE, Hannan MM, Semigran MJ, Uber PA, Baran DA, et al. The 2016 International Society for Heart Lung Transplantation listing criteria for heart transplantation: A 10-year update. J Heart Lung Transplant. 2016;35:1–23.

    Article  PubMed  Google Scholar 

  34. •• Kobashigawa J, Dadhania D, Bhorade S, Adey D, Berger J, Bhat G, et al. Report from the American Society of Transplantation on frailty in solid organ transplantation. Am J Transplant. 2019;19:984–94. (Consensus statement from the American Society of Transplantation on the current use of frailty assessments in solid organ transplant and ideal assessments to standardize frailty reporting for each organ.)

    Article  PubMed  Google Scholar 

  35. Chih S, McDonald M, Dipchand A, Kim D, Ducharme A, Kaan A, et al. Canadian Cardiovascular Society/Canadian Cardiac Transplant Network Position Statement on Heart Transplantation: Patient Eligibility, Selection, and Post-Transplantation Care. Can J Cardiol. 2020;36:335–56.

    Article  PubMed  Google Scholar 

  36. Leard LE, Holm AM, Valapour M, Glanville AR, Attawar S, Aversa M, et al. Consensus document for the selection of lung transplant candidates: An update from the International Society for Heart and Lung Transplantation. J Heart Lung Transplant. 2021;40:1349–79.

    Article  PubMed  PubMed Central  Google Scholar 

  37. Agarwal A, Neujahr DC. Frailty in Lung Transplantation: Candidate Assessment and Optimization. Transplantation. 2021;105:2201–12.

    Article  PubMed  Google Scholar 

  38. Schaenman JM, Diamond JM, Greenland JR, Gries C, Kennedy CC, Parulekar AD, et al. Frailty and aging-associated syndromes in lung transplant candidates and recipients. Am J Transplant. 2021;21:2018–24.

    Article  PubMed  Google Scholar 

  39. Montgomery E, Macdonald PS, Newton PJ, Jha SR, Malouf M. Frailty in lung transplantation: a systematic review. Expert Rev Respir Med. 2020;14:219–27.

    Article  CAS  PubMed  Google Scholar 

  40. Rudym D, Natalini JG, Trindade AJ. Listing Dilemmas: Age, Frailty, Weight, Preexisting Cancers, and Systemic Diseases. Clin Chest Med. 2023;44:35–46.

    Article  PubMed  Google Scholar 

  41. Varughese R, Rozenberg D, Singer LG. An update on frailty in lung transplantation. Curr Opin Organ Transplant. 2020;25:274–9.

    Article  PubMed  Google Scholar 

  42. Montgomery E, Macdonald PS, Newton PJ, Chang S, Jha SR, Hannu MK, et al. Frailty as a Predictor of Mortality in Patients With Interstitial Lung Disease Referred for Lung Transplantation. Transplantation. 2020;104:864–72.

    Article  PubMed  Google Scholar 

  43. Montgomery E, Newton PJ, Chang S, Peng W, Jha SR, Wilhelm K, et al. Frailty Measures in Patients Listed for Lung Transplantation. Transplantation. 2022;106:1084–92.

    Article  PubMed  Google Scholar 

  44. • Singer JP, Christie JD, Diamond JM, Anderson MA, Benvenuto LA, Gao Y, et al. Development of the Lung Transplant Frailty Scale (LT-FS). J Heart Lung Transplant. 2023;42:892–904. (Describes a lung transplant specific frailty scale and how it performs in the lung transplant population.)

    Article  PubMed  Google Scholar 

  45. Singer JP, Calfee CS, Delucchi K, Diamond JM, Anderson MA, Benvenuto LA, et al. Subphenotypes of frailty in lung transplant candidates. Am J Transplant. 2023;23:531–9.

    Article  PubMed  PubMed Central  Google Scholar 

  46. Swaminathan AC, McConnell A, Peskoe S, Bashir MR, Buckley EB, Frankel CW, et al. Evaluation of Frailty Measures and Short-term Outcomes After Lung Transplantation. Chest. 2023;164:159–68.

    Article  PubMed  Google Scholar 

  47. Singer JP, Diamond JM, Anderson MR, Katz PP, Covinsky K, Oyster M, et al. Frailty phenotypes and mortality after lung transplantation: A prospective cohort study. Am J Transplant. 2018;18:1995–2004.

    Article  PubMed  PubMed Central  Google Scholar 

  48. Singer JP, Diamond JM, Gries CJ, McDonnough J, Blanc PD, Shah R, et al. Frailty Phenotypes, Disability, and Outcomes in Adult Candidates for Lung Transplantation. Am J Respir Crit Care Med. 2015;192:1325–34.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  49. Rozenberg D, Mathur S, Wickerson L, Chowdhury NA, Singer LG. Frailty and clinical benefits with lung transplantation. J Heart Lung Transplant. 2018;37:1245–53.

    Article  PubMed  Google Scholar 

  50. Layton AM, Armstrong HF, Baldwin MR, Podolanczuk AJ, Pieszchata NM, Singer JP, et al. Frailty and maximal exercise capacity in adult lung transplant candidates. Respir Med. 2017;131:70–6.

    Article  PubMed  PubMed Central  Google Scholar 

  51. Venado A, McCulloch C, Greenland JR, Katz P, Soong A, Shrestha P, et al. Frailty trajectories in adult lung transplantation: A cohort study. J Heart Lung Transplant. 2019;38:699–707.

    Article  PubMed  PubMed Central  Google Scholar 

  52. Ali H, Soliman K, Mohamed MM, Rahman M, Herberth J, Fülöp T, et al. Impact of kidney transplantation on functional status. Ann Med. 2021;53:1303–9.

    Article  CAS  PubMed Central  Google Scholar 

  53. Alsaad R, Chen X, McAdams-DeMarco M. The clinical application of frailty in nephrology and transplantation. Curr Opin Nephrol Hypertens. 2021;30:593–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  54. Quint EE, Zogaj D, Banning LBD, Benjamens S, Annema C, Bakker SJL, et al. Frailty and Kidney Transplantation: A Systematic Review and Meta-analysis. Transplant Direct. 2021;7:e701.

    Article  PubMed  PubMed Central  Google Scholar 

  55. Cheng XS, Lentine KL, Koraishy FM, Myers J, Tan JC. Implications of Frailty for Peritransplant Outcomes in Kidney Transplant Recipients. Curr Transplant Rep. 2019;6:16–25.

    Article  PubMed  PubMed Central  Google Scholar 

  56. Clegg A, Young J, Iliffe S, Rikkert MO, Rockwood K. Frailty in elderly people. Lancet. 2013;381:752–62.

    Article  PubMed  Google Scholar 

  57. Basu A. Role of Physical Performance Assessments and Need for a Standardized Protocol for Selection of Older Kidney Transplant Candidates. Kidney Int Rep. 2019;4:1666–76.

    Article  PubMed  PubMed Central  Google Scholar 

  58. Sugimoto T, Arai H, Sakurai T. An update on cognitive frailty: Its definition, impact, associated factors and underlying mechanisms, and interventions. Geriatr Gerontol Int. 2022;22:99–109.

    Article  PubMed  Google Scholar 

  59. de Sire A, Ferrillo M, Lippi L, Agostini F, de Sire R, Ferrara PE, et al. Sarcopenic Dysphagia, Malnutrition, and Oral Frailty in Elderly: A Comprehensive Review. Nutrients. 2022;14:982.

    Article  PubMed  PubMed Central  Google Scholar 

  60. Whitesides L, Lynn J. The Psychosocial Effects of Frailty on Women. Clin Geriatr Med. 2021;37:543–52.

    Article  PubMed  Google Scholar 

  61. Clegg A, Hassan-Smith Z. Frailty and the endocrine system. Lancet Diabetes Endocrinol. 2018;6:743–52.

    Article  CAS  PubMed  Google Scholar 

  62. Perito ER, Bucuvalas J, Lai JC. Functional status at listing predicts waitlist and posttransplant mortality in pediatric liver transplant candidates. Am J Transplant. 2019;19:1388–96.

    Article  PubMed  Google Scholar 

  63. Snyder JJ, Salkowski NJ, Lamb KE, Zaun DA, Khaled TA, Israni AK, et al. Karnofsky Performance Score and Its Use in Risk Adjustment of Transplant Outcomes in the United States.

  64. Rohrmann S. Epidemiology of Frailty in Older People. Adv Exp Med Biol. 2020;1216:21–7.

    Article  PubMed  Google Scholar 

  65. O’Caoimh R, Sezgin D, O’Donovan MR, Molloy DW, Clegg A, Rockwood K, et al. Prevalence of frailty in 62 countries across the world: a systematic review and meta-analysis of population-level studies. Age Ageing. 2021;50:96–104.

    Article  PubMed  Google Scholar 

  66. Usher T, Buta B, Thorpe RJ, Huang J, Samuel LJ, Kasper JD, et al. Dissecting the Racial/Ethnic Disparity in Frailty in a Nationally Representative Cohort Study with Respect to Health, Income, and Measurement. J Gerontol A Biol Sci Med Sci. 2021;76:69–76.

    Article  PubMed  Google Scholar 

  67. Abd Ghafar MZA, O’Donovan M, Sezgin D, Moloney E, Rodríguez-Laso Á, Liew A, et al. Frailty and diabetes in older adults: Overview of current controversies and challenges in clinical practice. Front Clin Diabetes Healthc. 2022;3:895313.

    Article  PubMed  PubMed Central  Google Scholar 

  68. Vanitallie TB. Frailty in the elderly: contributions of sarcopenia and visceral protein depletion. Metabolism. 2003;52:22–6.

    Article  PubMed  Google Scholar 

  69. Johansen KL, Dalrymple LS, Delgado C, Chertow GM, Segal MR, Chiang J, et al. Factors Associated with Frailty and Its Trajectory among Patients on Hemodialysis. Clin J Am Soc Nephrol. 2017;12:1100–8.

    Article  PubMed  PubMed Central  Google Scholar 

  70. •• McAdams-DeMarco MA, Van Pilsum Rasmussen SE, Chu NM, Agoons D, Parsons RF, Alhamad T, et al. Perceptions and Practices Regarding Frailty in Kidney Transplantation: Results of a National Survey. Transplantation. 2020;104:349–56. (National survey study assessing the modality and frequency of frailty screening in kidney transplant patients.)

    Article  PubMed  PubMed Central  Google Scholar 

  71. Kennard AL, Rainsford S, Glasgow NJ, Talaulikar GS. Use of frailty assessment instruments in nephrology populations: a scoping review. BMC Geriatr. 2023;23:449.

    Article  PubMed  PubMed Central  Google Scholar 

  72. Parajuli S, Aziz F, Garg N, Wallschlaeger RE, Lorden HM, Al-Qaoud T, et al. Frailty in Pancreas Transplantation. Transplantation. 2021;105:1685–94.

    Article  PubMed  Google Scholar 

  73. Parsons RF, Tantisattamo E, Cheungpasitporn W, Basu A, Lu Y, Lentine KL, et al. Comprehensive review: Frailty in pancreas transplant candidates and recipients. Clin Transplant. 2023;37:e14899.

    Article  PubMed  Google Scholar 

  74. Lentine KL, Alhamad T, Cheungpasitporn W, Tan JC, Chang S-H, Cooper M, et al. Impact of Functional Status on Outcomes of Simultaneous Pancreas-kidney Transplantation: Risks and Opportunities for Patient Benefit. Transplant Direct. 2020;6:e599.

    Article  PubMed  PubMed Central  Google Scholar 

  75. Meier RPH, Noguchi H, Kelly YM, Sarwal M, Conti G, Ward C, et al. Impact of Sarcopenia on Simultaneous Pancreas and Kidney Transplantation Outcomes: A Retrospective Observational Cohort Study. Transplant Direct. 2020;6:e610.

    Article  PubMed  PubMed Central  Google Scholar 

  76. Fukuda Y, Asaoka T, Eguchi H, Sasaki K, Iwagami Y, Yamada D, et al. Clinical Impact of Preoperative Sarcopenia on the Postoperative Outcomes After Pancreas Transplantation. World J Surg. 2018;42:3364–71.

    Article  PubMed  Google Scholar 

  77. Aby ES, Saab S. Frailty, Sarcopenia, and Malnutrition in Cirrhotic Patients. Clin Liver Dis. 2019;23:589–605.

    Article  PubMed  Google Scholar 

  78. Buchard B, Boirie Y, Cassagnes L, Lamblin G, Coilly A, Abergel A. Assessment of Malnutrition, Sarcopenia and Frailty in Patients with Cirrhosis: Which Tools Should We Use in Clinical Practice? Nutrients. 2020;12:186.

    Article  PubMed  PubMed Central  Google Scholar 

  79. Chong J, Guorgui J, Coy H, Ito T, Lu M, DiNorcia J, et al. Perioperative Skeletal Muscle Fluctuations in High-Acuity Liver Transplantation. J Surg Res. 2022;270:386–93.

    Article  PubMed  Google Scholar 

  80. Tandon P, Ney M, Irwin I, Ma MM, Gramlich L, Bain VG, et al. Severe muscle depletion in patients on the liver transplant wait list: its prevalence and independent prognostic value. Liver Transpl. 2012;18:1209–16.

    Article  PubMed  Google Scholar 

  81. van Vugt JLA, Buettner S, Alferink LJM, Bossche N, de Bruin RWF, Darwish Murad S, et al. Low skeletal muscle mass is associated with increased hospital costs in patients with cirrhosis listed for liver transplantation-a retrospective study. Transpl Int. 2018;31:165–74.

    Article  PubMed  Google Scholar 

  82. Tandon P, Zanetto A, Piano S, Heimbach JK, Dasarathy S. Liver transplantation in the patient with physical frailty. J Hepatol. 2023;78:1105–17.

    Article  PubMed  PubMed Central  Google Scholar 

  83. Ferreira AP, Machado MV. Impact of pretransplant frailty and sarcopenia on the post-transplant prognosis of patients with liver cirrhosis: a systematic review. Eur J Gastroenterol Hepatol. 2021;33:e883–97.

    Article  PubMed  Google Scholar 

  84. Kahn J, Wagner D, Homfeld N, Müller H, Kniepeiss D, Schemmer P. Both sarcopenia and frailty determine suitability of patients for liver transplantation-A systematic review and meta-analysis of the literature. Clin Transplant. 2018;32:e13226.

    Article  PubMed  Google Scholar 

  85. Lai JC, Feng S, Terrault NA, Lizaola B, Hayssen H, Covinsky K. Frailty predicts waitlist mortality in liver transplant candidates. Am J Transplant. 2014;14:1870–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  86. Lai JC, Dodge JL, Kappus MR, Dunn MA, Volk ML, Duarte-Rojo A, et al. Changes in frailty are associated with waitlist mortality in patients with cirrhosis. J Hepatol. 2020;73:575–81.

    Article  PubMed  PubMed Central  Google Scholar 

  87. Lai JC, Shui AM, Duarte-Rojo A, Ganger DR, Rahimi RS, Huang C-Y, et al. Frailty, mortality, and health care utilization after liver transplantation: From the Multicenter Functional Assessment in Liver Transplantation (FrAILT) Study. Hepatology. 2022;75:1471–9.

    Article  PubMed  Google Scholar 

  88. Kang SH, Jeong WK, Baik SK, Cha SH, Kim MY. Impact of sarcopenia on prognostic value of cirrhosis: going beyond the hepatic venous pressure gradient and MELD score. J Cachexia Sarcopenia Muscle. 2018;9:860–70.

    Article  PubMed  PubMed Central  Google Scholar 

  89. Bhanji RA, Watt KD. Physiologic Reserve Assessment and Application in Clinical and Research Settings in Liver Transplantation. Liver Transpl. 2021;27:1041–53.

    Article  PubMed  Google Scholar 

  90. •• Lai JC, Covinsky KE, Dodge JL, Boscardin WJ, Segev DL, Roberts JP, et al. Development of a novel frailty index to predict mortality in patients with end-stage liver disease. Hepatology. 2017;66:564–74. (Formulates a new liver specific frailty scoring system consisting of three easily measured physical tests that correlates with mortality.)

    Article  PubMed  Google Scholar 

  91. Kardashian A, Ge J, McCulloch CE, Kappus MR, Dunn MA, Duarte-Rojo A, et al. Identifying an Optimal Liver Frailty Index Cutoff to Predict Waitlist Mortality in Liver Transplant Candidates. Hepatology. 2021;73:1132–9.

    Article  CAS  PubMed  Google Scholar 

  92. Lai JC, Covinsky KE, McCulloch CE, Feng S. The Liver Frailty Index Improves Mortality Prediction of the Subjective Clinician Assessment in Patients With Cirrhosis. Am J Gastroenterol. 2018;113:235–42.

    Article  PubMed  Google Scholar 

  93. Skladany L, Drotarova Z, Vnencakova J, Jancekova D, Molcan P, Koller T. Applicability and prognostic value of frailty assessment tools among hospitalized patients with advanced chronic liver disease. Croat Med J. 2021;62:8–16.

    Article  PubMed  PubMed Central  Google Scholar 

  94. Lai JC, Sonnenday CJ, Tapper EB, Duarte-Rojo A, Dunn MA, Bernal W, et al. Frailty in liver transplantation: An expert opinion statement from the American Society of Transplantation Liver and Intestinal Community of Practice. Am J Transplant. 2019;19:1896–906.

    Article  PubMed  PubMed Central  Google Scholar 

  95. Lai JC, Tandon P, Bernal W, Tapper EB, Ekong U, Dasarathy S, et al. Malnutrition, Frailty, and Sarcopenia in Patients With Cirrhosis: 2021 Practice Guidance by the American Association for the Study of Liver Diseases. Hepatology. 2021;74:1611–44.

    Article  PubMed  Google Scholar 

  96. Lai JC. Defining the threshold for too sick for transplant. Curr Opin Organ Transplant. 2016;21:127–32.

    Article  PubMed  PubMed Central  Google Scholar 

  97. Weiss E, Saner F, Asrani SK, Biancofiore G, Blasi A, Lerut J, et al. When Is a Critically Ill Cirrhotic Patient Too Sick to Transplant? Development of Consensus Criteria by a Multidisciplinary Panel of 35 International Experts. Transplantation. 2021;105:561–8.

    Article  PubMed  Google Scholar 

Download references

Funding

There was no external funding for this manuscript.

Author information

Authors and Affiliations

Authors

Contributions

A.C and M.H-S conceptualized the paper. All authors wrote manuscript text and reviewed the manuscript.

Corresponding author

Correspondence to Arielle Cimeno.

Ethics declarations

Competing interests

The authors declare no competing interests.

Conflict of Interest

The authors have no conflicts of interest to disclose.

Human and Animal Rights and Informed Consent Statement:

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cimeno, A., Madariaga, M.L.L., Basu, A. et al. Clinical Application of Frailty in the Evaluation of Solid Organ Transplant Patients. Curr Transpl Rep (2024). https://doi.org/10.1007/s40472-024-00436-6

Download citation

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s40472-024-00436-6

Keywords

Navigation